212 related articles for article (PubMed ID: 6488005)
1. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
Weidenfeld J; Corcos AP; Wohlman A; Feldman S
Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cerebral intraventricular administration of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the cyclic secretion of corticosterone in the rat].
Montilla P; Pinilla J; Muñoz MC; Clavero RM
Rev Esp Fisiol; 1984 Sep; 40(3):333-9. PubMed ID: 6522800
[TBL] [Abstract][Full Text] [Related]
4. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
[TBL] [Abstract][Full Text] [Related]
5. Effect of some neonatal treatments on the hypothalamic-pituitary-adrenocortical function.
Ogawa T; Kuroda Y; Mikuni M; Takahashi K
Jpn J Psychiatry Neurol; 1993 Jun; 47(2):416-7. PubMed ID: 8271618
[No Abstract] [Full Text] [Related]
6. Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses.
Feldman S; Newman ME; Gur E; Weidenfeld J
Neuroreport; 1998 Jun; 9(9):2007-9. PubMed ID: 9674583
[TBL] [Abstract][Full Text] [Related]
7. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
8. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
9. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to 5-hydroxytryptamine due to intraventricular administration of 5,6-dihydroxytryptamine.
Kawa A; Ariyama T; Taniguchi Y; Kamisaki T; Kanehisa T
Acta Endocrinol (Copenh); 1978 Nov; 89(3):432-7. PubMed ID: 707004
[TBL] [Abstract][Full Text] [Related]
11. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
12. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
Frankfurt M; Allen DL; Luine VN; Beaudet A
Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
14. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats.
Widmaier EP; Rosen K; Abbott B
Endocrinology; 1992 Nov; 131(5):2313-8. PubMed ID: 1330498
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
[TBL] [Abstract][Full Text] [Related]
17. Short days increase hypothalamic-pituitary-adrenal axis responsiveness.
Pyter LM; Adelson JD; Nelson RJ
Endocrinology; 2007 Jul; 148(7):3402-9. PubMed ID: 17395702
[TBL] [Abstract][Full Text] [Related]
18. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
[No Abstract] [Full Text] [Related]
19. Chronic alcohol administration increases corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF
Biol Psychiatry; 1984 Dec; 19(12):1725-9. PubMed ID: 6518219
[No Abstract] [Full Text] [Related]
20. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
